Literature DB >> 7751682

Characterization of human proliferative T cell responses to adenovirus.

P Flomenberg1, V Piaskowski, R L Truitt, J T Casper.   

Abstract

Although cellular immune responses are likely important for recovery from acute adenovirus infection, they have not been studied in humans. As a first step, a sensitive assay for the detection of adenovirus-specific proliferative T cell responses was developed. Peripheral blood mononuclear cells from 29 of 30 healthy adults exhibited specific proliferative responses to adenovirus type 2 antigen. Adenovirus-specific proliferation was found to be mediated by CD4+ T cells. Specific proliferative responses were detected to purified Ad2 virions and by Ad2-infected cell lysates, indicating that adenovirus structural proteins are important targets. In addition, specific proliferative responses to the uncommon adenovirus type 35 were found in persons without serologic evidence of prior Ad35 infection. These data suggest that adenovirus-specific CD4+ T cells recognize conserved antigens among different serotypes and that a majority of persons develop long-lived CD4+ T cell responses to adenovirus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7751682     DOI: 10.1093/infdis/171.5.1090

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

Review 1.  The promise and potential hazards of adenovirus gene therapy.

Authors:  L S Young; V Mautner
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

2.  Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors.

Authors:  Mieke C Sprangers; Wandena Lakhai; Wouter Koudstaal; Marielle Verhoeven; Björn F Koel; Ronald Vogels; Jaap Goudsmit; Menzo J E Havenga; Stefan Kostense
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

3.  Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity.

Authors:  Ronald Vogels; David Zuijdgeest; Richard van Rijnsoever; Eric Hartkoorn; Irma Damen; Marie-Pierre de Béthune; Stefan Kostense; Germaine Penders; Niels Helmus; Wouter Koudstaal; Marco Cecchini; Antoinette Wetterwald; Mieke Sprangers; Angelique Lemckert; Olga Ophorst; Björn Koel; Michelle van Meerendonk; Paul Quax; Laura Panitti; Jos Grimbergen; Abraham Bout; Jaap Goudsmit; Menzo Havenga
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

4.  Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States.

Authors:  Edward Nwanegbo; Eftyhia Vardas; Wentao Gao; Hilton Whittle; Huijie Sun; David Rowe; Paul D Robbins; Andrea Gambotto
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

5.  Comparison of in-house real-time quantitative PCR to the Adenovirus R-Gene kit for determination of adenovirus load in clinical samples.

Authors:  Hélène Jeulin; Alexandra Salmon; Pierre Bordigoni; Véronique Venard
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

6.  Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer.

Authors:  E J Kremer; S Boutin; M Chillon; O Danos
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Fell Pony syndrome: characterization of developmental hematopoiesis failure and associated gene expression profiles.

Authors:  Rebecca L Tallmadge; Tracy Stokol; Mary Jean Gould-Earley; Ed Earley; Erica J Secor; Mary Beth Matychak; M Julia B Felippe
Journal:  Clin Vaccine Immunol       Date:  2012-05-16

8.  Identification of HI-like loop in CELO adenovirus fiber for incorporation of receptor binding motifs.

Authors:  Denis Y Logunov; Olga V Zubkova; Anna S Karyagina-Zhulina; Eugenia A Shuvalova; Andrei P Karpov; Maxim M Shmarov; Irina L Tutykhina; Yulia S Alyapkina; Natalia M Grezina; Natalia A Zinovieva; Lev K Ernst; Alexsandr L Gintsburg; Boris S Naroditsky
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

9.  Three-dimensional structure of canine adenovirus serotype 2 capsid.

Authors:  Guy Schoehn; Majida El Bakkouri; Céline M S Fabry; Oliver Billet; Leandro F Estrozi; Long Le; David T Curiel; Andrey V Kajava; Rob W H Ruigrok; Eric J Kremer
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

Review 10.  The conundrum between immunological memory to adenovirus and their use as vectors in clinical gene therapy.

Authors:  Matthieu Perreau; E J Kremer
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.